Autres langues AstraZeneca PLC

Actions

AZN

GB0009895292

Produits pharmaceutiques

Marché Fermé - London S.E. Autres places de cotation 17:35:02 06/08/2026			Varia. 5j.	Varia. 1 janv.
11 850,00 ^GBX	-1,55%		-9,78%	-14,07%

18:14	Les grandes capitalisations reculent, mais le FTSE 250 poursuit sa série de victoires	AN
17:40	Yubico s'envole sur une Bourse de Stockholm atone, l'indice OMXS30 inchangé	FW

Autres langues

18:14	Blue chips fall but FTSE 250 extends winning run
08:46	Morning Meeting: El oro despierta y los chips sufren una corrección
08:38	Morning Meeting: Die Märkte gleiten langsam in die Sommerflaute
08:14	Markets Drift Gently Towards the Mid-August Lull
04:18	US FDA approves first mRNA flu shot from Moderna
02:12	AstraZeneca, Jaguar Land Rover Gain Access to UK's Fast-Track Visa
05/08	AstraZeneca Is Said to Have Explored Bristol Myers Merger
05/08	FTSE 100 rises, led by Glencore, Next earnings; banks slide
05/08	AstraZeneca, Bristol Myers Not Pursuing Merger Talks
05/08	European Stocks Close Mostly Higher in Wednesday Trading as Investors Monitor Middle East Developments
05/08	European Equities Traded in the US as American Depositary Receipts Edge Up in Wednesday Trading
05/08	INTERVIEW/Novo-Nordisk-CEO offen für ergänzende Übernahmen
05/08	AstraZeneca, Bristol Myers Not Pursuing Merger Talks
05/08	AstraZeneca Pays CSPC $10 Million for Exercise of License Option for Pre-clinical Candidate Program
05/08	AstraZeneca, Bristol Myers Squibb Reportedly Not Discussing Merger
05/08	AstraZeneca, CSPC Pharmaceutical Group Form JV for Biologics Manufacturing Facility in China
05/08	"No hay conversaciones" sobre acuerdo entre AstraZeneca y Bristol Myers: fuente
05/08	'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
05/08	CSPC Pharma Gets $10 Million Milestone Payment from AstraZeneca Under Research Deal
05/08	CSPC Pharma, AstraZeneca Form JV to Build Biologics Manufacturing Facility in China
05/08	Wall Street warms to healthcare stocks as tech trade faces turbulence
04/08	Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies
04/08	Bristol Myers Squibb Potential Deal With AstraZeneca Seen Unlikely as Shareholder Views Diverge, RBC Says
04/08	AstraZeneca Collaborates With Sophia Genetics on Companion Diagnostics for Oncology Therapies
04/08	SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies